In moving toward a systems level understanding of the MGBA and leveraging advances in microbiome science-the LBPs-it is all possible to usher in a new era of preventive and therapeutic agendas toward complex neuropsychiatric and neurodegenerative disorders
That said, more studies need to be conducted before we draw any firm conclusions [12][13]
Target blood glucose levels should be individualised, but generally, readings below 4.0 mmol/L indicate hypoglycaemia requiring treatment with fast-acting carbohydrate (1520g, such as glucose tablets or a small glass of fruit juice), followed by a longer-acting carbohydrate snack
Jan 15, 2026 | 2 min read GLP-1 users are not abandoning restaurants but are significantly altering their ordering behaviors, according to research firm Circana
Fatigue is often most noticeable during initial dose escalation and may recur with each dose increase, which typically occurs every 4 weeks per FDA-approved dosing schedules
PlexusDx Precision Peptide Genetic Test analyzes your GLP1R and GIPR variants plus FTO and MC4R pathways, revealing your individual predisposition to rapid appetite rebound and metabolic flexibility
